Concord Drugs Limited (BOM:538965)
India · Delayed Price · Currency is INR 73.02
+1.01 (1.40%)
At close: Mar 5, 2026
Concord Drugs Market Cap
Concord Drugs has a market cap or net worth of 962.04 million as of March 5, 2026. Its market cap has increased by 204.83% in one year.
Market Cap
962.04M
Enterprise Value
1.15B
Revenue
512.41M
Ranking
n/a
PE Ratio
160.63
Stock Price
73.02
Market Cap Chart
Since February 23, 2015, Concord Drugs's market cap has increased from 144.80M to 962.04M, an increase of 564.38%. That is a compound annual growth rate of 18.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 962.04M | -11.47% |
| Dec 31, 2025 | 1.09B | 188.24% |
| Dec 31, 2024 | 377.00M | -36.87% |
| Dec 29, 2023 | 597.20M | 109.83% |
| Dec 30, 2022 | 284.61M | 1.24% |
| Dec 31, 2021 | 281.11M | 40.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aayush Wellness | 1.45B |
| Bilcare | 1.40B |
| Bal Pharma | 1.19B |
| Pharmaids Pharmaceuticals | 1.15B |
| Lactose (India) | 1.14B |
| Mercury Laboratories | 948.00M |
| Makers Laboratories | 832.84M |
| Source Natural Foods and Herbal Supplements | 794.96M |